(Q40489140)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689074%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

review article

1 reference

title

Biologicals and hematopoietic cytokines in prevention or treatment of infections in immunocompromised hosts (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689074%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

author name string

Roilides E

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689074%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

Pizzo PA

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689074%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

publication date

1 August 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689074%20AND%20SRC:MED&resulttype=core&format=json

Hematology / Oncology Clinics of North America

23 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689074%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689074%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689074%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

page(s)

841-864

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689074%20AND%20SRC:MED&resulttype=core&format=json

Polyvalent Pneumococcal-Polysaccharide Immunization of Patients with Sickle-Cell Anemia and Patients with Splenectomy

23 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Recombinant human tumor necrosis factor-alpha. Regulation of N-formylmethionylleucylphenylalanine receptor affinity and function on human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Interleukin-1 and hematopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Alteration of some leukocyte functions following in vivo and in vitro exposure to recombinant bovine alpha- and gamma-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Antibody responses to polyvalent pneumococcal vaccine in infants with sickle cell anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Prophylactic or Simultaneous Administration of Recombinant Human Granulocyte Colony Stimulating Factor in the Treatment of Group B Streptococcal Sepsis in Neonatal Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Treatment of Gram-Negative Septic Shock with Human IgG Antibody to Escherichia coli J5: A Prospective, Double-Blind, Randomized Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Macrophage colony-stimulating factor in murine candidiasis: serum and tissue levels during infection and protective effect of exogenous administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

In vivo stimulation of granulopoiesis by recombinant human granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Prevention of cytomegalovirus infection by prophylaxis with an intravenous, hyperimmune, native, unmodified cytomegalovirus globulin. Randomized trial in bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Enhanced hematopoietic activity of a human granulocyte/macrophage colony-stimulating factor-interleukin 3 fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

A Phase I/II Trial of Zidovudine, Interferon- , and Granulocyte-Macrophage Colony-Stimulating Factor in the Treatment of Human Immunodeficiency Virus Type 1 Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Disparate effects of interferon-gamma and tumor necrosis factor-alpha on early neutrophil respiratory burst and fungicidal responses to Candida albicans hyphae in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Effects of tumour necrosis factor alpha and interleukin-1 alpha and beta on human neutrophil migration, respiratory burst and degranulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

The intracellular fate of Histoplasma capsulatum in human macrophages is unaffected by recombinant human interferon-gamma.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

The ability of recombinant murine granulocyte-macrophage colony-stimulating factor to protect neonatal rats from septic death due to Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

The effect of recombinant human granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity in chronic severe neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Interleukin 1 enhances growth factor-dependent proliferation of the clonogenic cells in acute myeloblastic leukemia and of normal human primitive hemopoietic precursors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Antibody Responses After Influenza and Pneumococcal Immunization in HIV-Infected Homosexual Men

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Impaired response to pneumococcal vaccine in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Use of recombinant human interferon gamma to enhance neutrophil chemotactic responses in Job syndrome of hyperimmunoglobulinemia E and recurrent infections

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

In vivo effects of macrophage colony-stimulating factor on human monocyte function

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Recombinant human granulocyte colony-stimulating factor enhances superoxide release in human granulocytes stimulated by the chemotactic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Antibody to Mol abrogates the increase in neutrophil phagocytosis and degranulation induced by granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Cytokines alter production of HIV-1 from primary mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Combined effect of fluconazole and recombinant human interleukin-1 on systemic candidiasis in neutropenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Replacement of the cytoplasmic domain alters sorting of a viral glycoprotein in polarized cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Recombinant murine granulocyte-macrophage colony-stimulating factor augments neutrophil recovery and enhances resistance to infections in myelosuppressed mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Therapeutic evaluation of interleukin-1 for stimulation of hematopoiesis in primates after autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Activation of murine polymorphonuclear neutrophils for fungicidal activity by recombinant gamma interferon.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Gamma interferon, cytokine-induced macrophage activation, and antimicrobial host defense. In vitro, in animal models, and in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Stimulation by conditioned medium of L-929 fibroblasts, E. coli lipopolysaccharide, and muramyl dipeptide of candidacidal activity of mouse macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Effect of Granulocyte Colony-Stimulating Factor after Intensive Induction Therapy in Relapsed or Refractory Acute Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Potentiation of neutrophil function by recombinant DNA-produced interleukin 1a

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Management of septic shock: present and future

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

1 reference

7 January 2021

Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Impairment of neutrophil chemotactic and bactericidal function in children infected with human immunodeficiency virus type 1 and partial reversal after in vitro exposure to granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Neutrophil oxidative burst in response to blastoconidia and pseudohyphae of Candida albicans: augmentation by granulocyte colony-stimulating factor and interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Recombinant bovine interferon-gamma as an immunomodulator in dexamethasone-treated and nontreated cattle

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

The effect of granulocyte colony-stimulating factor (G-CSF) upon burn-induced defective neutrophil chemotaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Gamma-interferon restores listericidal activity and concurrently enhances release of reactive oxygen metabolites in dexamethasone-treated human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Antibody Response to Pneumococcal Vaccine in Patients with Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Antibody response to pretreatment immunization and post-treatment boosting with bacterial polysaccharide vaccines in patients with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Human recombinant granulocyte-macrophage colony-stimulating factor: a multilineage hematopoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Stimulation of human hematopoietic colony formation by recombinant gibbon multi-colony-stimulating factor or interleukin 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Granulocyte-macrophage colony-stimulating factor augments human monocyte fungicidal activity for Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Analysis in serum-free culture of the targets of recombinant human hemopoietic growth factors: interleukin 3 and granulocyte/macrophage-colony-stimulating factor are specific for early developmental stages

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Activation of bovine neutrophils by recombinant interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Intravenous immunoglobulins as therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Protective effect of recombinant murine granulocyte-macrophage colony-stimulating factor against Pseudomonas aeruginosa infection in leukocytopenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Hematopoietic effects of a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Effect of colony stimulating factor on murine macrophages. Induction of antitumor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Human CSF-1: molecular cloning and expression of 4-kb cDNA encoding the human urinary protein

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Human IL-3 (multi-CSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Effect of granulocyte colony-stimulating factor on neutropenia due to chemotherapy for non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930224-7

7 January 2021

10.1016/S0889-8588(18)30224-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689074%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference